InMed to Present at Canaccord Genuity’s 4th Annual Cannabis Conference

May 7, 2020

Read More »

InMed and Almac Group Developing Improved Cannabinoid Production Methods

May 5, 2020

Read More »

InMed Receives CTA Approval for Second Phase 1 Clinical Trial with INM-755

April 30, 2020

Read More »

InMed Announces Completion of Initial Phase 1 Clinical Trial of INM-755 CBN Cream in Healthy Subjects

April 1, 2020

Read More »

InMed Submits Clinical Trial Application to Evaluate INM-755 in Second Phase 1 Trial

March 24, 2020

Read More »

InMed Provides Update on Operations in Response to the COVID-19 Global Outbreak

March 20, 2020

Read More »

InMed Pharmaceuticals Announces Completed Enrollment in Phase 1 Clinical Trial of INM-755 CBN Cream in Healthy Subjects

March 10, 2020

Read More »

InMed Pharmaceuticals Reports Second Quarter Fiscal 2020 Financial Results and Provides R&D and Business Update

February 14, 2020

Read More »

InMed Pharmaceuticals to Report Second Quarter Fiscal 2020 Financial Results and Business Update on February 14, 2020

February 7, 2020

Read More »

InMed Expands on Announcement of Cannabinol (CBN) Therapeutic Leadership with New Website Content and CEO Interview

January 21, 2020

Read More »

InMed First to Advance Cannabinol (CBN) into Therapeutic Clinical Trials

January 20, 2020

Read More »

InMed Pharmaceuticals to Attend and Exhibit at EB2020 World Congress

January 16, 2020

Read More »

InMed Announces Election of Directors

January 10, 2020

Read More »

InMed Pharmaceuticals to Present at the Biotech Showcase Conference

January 8, 2020

Read More »

InMed Receives Clinical Trial Application Approval for INM-755, a Rare Cannabinoid Formulation Under Development for the Treatment of Epidermolysis Bullosa

December 9, 2019

Read More »

InMed Pharmaceuticals to Present at the Cowen Conference

November 11, 2019

Read More »

InMed Pharmaceuticals Reports First Quarter Fiscal 2020 Financial Results and Provides R&D and Business Update

November 8, 2019

Read More »

InMed Submits Clinical Trial Application to Evaluate INM-755 in Phase 1 Trial

November 5, 2019

Read More »

InMed Pharmaceuticals to Report First Quarter Fiscal 2020 Financial Results and Business Update on November 8, 2019

November 4, 2019

Read More »

InMed Pharmaceuticals to Present at the BIO Investor Forum

October 18, 2019

Read More »